Latest news with #Hypha
AsiaOne
20-05-2025
- Business
- AsiaOne
We check out Hiap Joo Bakery's new vending machine selling its famous banana cake, Lifestyle News
When it was announced that there is a vending machine in Singapore selling Malaysian bakery Hiap Joo Bakery & Biscuit Factory's famous banana cake, people went crazy. Prior to this, Singaporeans could only purchase their banana cake by crossing the Causeway to JB. Located in Senja Hawker Centre, the vending machine only doled out boxes of banana cake, with each containing 10 pieces. The stock was wiped clean in a few days and when AsiaOne paid the machine a visit on Saturday (May 17), there was nothing left. But fret not, these will be restocked soon on May 21, Hypha, the company behind the vending machines, told AsiaOne. Hypha shared that the machine is restocked every day except Mondays at 11.30am and 4.30pm. If Bukit Panjang is too out of the way for you, you'll be glad to know that there are plans in the pipeline to place more Hiap Joo Bakery vending machines in the north and east parts of Singapore. However, there are no confirmed locations at the moment. Hypha also shared that while it aims to be a platform for local businesses to get more physical exposure through its vending network, it also hopes to introduce more overseas delicacies to Singapore through its vending machines. Gone are the times where vending machines only sold canned and packet drinks. Apart from Hiap Joo Bakery's machine, there have been others popping up around Singapore dispensing a variety of interesting items. For instance, earlier in February, traditional bakery Uncle Lee Confectionary collaborated with Hypha to set up one selling whole cakes at Woodleigh Village Hawker Centre. And in January, hawker bakery Buttertown, known for its shio pans (Japanese salted butter rolls) launched its own machine, too. There have also been vending machines spotted dispensing durians, gold bars and fresh flowers. [[nid:530366]] melissateo@
Yahoo
12-05-2025
- Business
- Yahoo
Emerging Markets Report: A Milestone for Mycelium
Underreported D.E.A. Letter and Policy Position Could be a Game Changer for Mushroom Enthusiasts An Emerging Markets Sponsored Commentary ORLANDO, Fla., May 12, 2025 (GLOBE NEWSWIRE) -- At the Emerging Market Report we are comprised of a team of veteran journalists, authors, former stock brokers, financial professionals, and unabashed opportunists who all come together to publish these tidy missives on our client profiles. We are constantly searching for impactful news that could be gamechangers for the Companies we cover. And we sure missed a big did just about everybody else. That big piece could be a major catalyst for Hypha Labs (OTCQB: FUNI) which makes the first at-home and commercial patent-pending mushroom ingredient maker of its kind. The elevator pitch is that Hypha Labs is to mushrooms as the clever Keurig was, is, to coffee. Massive potential disruptor in a massive market. Hypha's story is already a game changer as it is going to allow the soccer mom at home to make her preferred mushroom ingredient in a simple eight-day cycle. Pop in a cartridge, scan the bar code, wait eight days and enjoy the magic of the privacy, no more growing 'shrooms in animal feces. But the mushroom industry is a decade or more behind the Emancipation of Cannabis. That cannabis revolution has almost completely come already with weed available most everywhere and a reasonable expectation that the government will change the arcane way it is classified/scheduled at the federal cannabis movement started simply enough; some vocal folk argued the medicinal benefits AND the economic benefits to states that would listen and states started to go green. Once a few states implemented pro-Cannabis legislation they provided good working test market examples for other states to see that there wasn't a new filming of Reefer Madness on the streets and there were indeed many a cannabis driven dollar going into the state coffers that could be used for things like better schools and roads. I've buried the lead here but then again, it's been buried for a long, long time. Don't kill the the buried bombshell: The Drug Enforcement Agency (DEA) appears to have taken a firm position that mycelium is ok to ship across state lines, although there are three states which currently don't allow mycelium to be shipped across state lines. Mycelium is the inactive root-like structure which later becomes a mushroom when it begins to fruit, which is what happens when it is fed nutrients. That's pretty good news if you're a company like Hypha Labs that will ship mycelium across eligible state lines once the retail roll-out of the Micropearls machine goes live. As described, Hypha sends you mycelium and based on your desires and a little A.I. you set your eight day harvest to whatever mushroom crop you're feelin'. Here are two sources for the D.E.A.'s position, which of course, come from cannabis sources who know what this means for the mushroom. One has an actual letter from the D.E.A. to the inquiring attorney way down at the bottom of the page. Read on either headline to read the coverage:DEA CONFIRMS PSYCHEDELIC MUSHROOM SPORES ARE LEGAL DEA Confirms That Psychedelic Mushroom Spores Are Federally Legal Prior To Germination (DEA letter at the bottom.) What is absolutely bizarre is we can find ZERO national news coverage other than these industry blogs. And we are good at means you are among the very few who knows about the milestone moment for mycelium and mushrooms and what an absolute gamechanger it is for Hypha Labs and their magical Micropearls. As this article was being prepared for release, breaking news from New Mexico warrants mention. The state's governor has signed a bill allowing for psilocybin use in the state. As indicated in this release from Hypha, this is a massive step forward to acceptance and a rapidly expanding market for Hypha Lab's revolutionary Micro Pearls device. More on Hypha here. We intend to cover Hypha Labs for the next couple months at minimum and to closely track their development and execution of their business model. If you see what we see, we suggest you add the ticker 'FUNI' to your watchlist and take a moment to review the Company's Investor Presentation at the following link: About The Emerging Markets Report:The Emerging Markets Report is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing years of experience. Our network consists of stockbrokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets. For more informative reports such as this, please sign up at Must Read OTC Markets/SEC policy on stock promotion and investor protection Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below. We may purchase Securities of the Profiled Company prior to their securities becoming publicly traded, which we may later sell publicly before, during or after our dissemination of the Information, and make profits therefrom. EMC does not verify or endorse any medical claims for any of its client companies. The Company's external Investor Relations firm, Integrity Media Inc, has contributed significantly to this report and holds or is owed six-million shares through a current or previous service agreement. EMC has been paid $50,000 by Hypha Labs on its own behalf for various marketing services including this report. EMC does not independently verify any of the content linked to this editorial. Please see our full disclaimer. For media inquiries, please contact Maggie Caraway at maggie@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
12-05-2025
- Business
- Associated Press
Emerging Markets Report: A Milestone for Mycelium
Underreported D.E.A. Letter and Policy Position Could be a Game Changer for Mushroom Enthusiasts An Emerging Markets Sponsored Commentary ORLANDO, Fla., May 12, 2025 (GLOBE NEWSWIRE) -- At the Emerging Market Report we are comprised of a team of veteran journalists, authors, former stock brokers, financial professionals, and unabashed opportunists who all come together to publish these tidy missives on our client profiles. We are constantly searching for impactful news that could be gamechangers for the Companies we cover. And we sure missed a big piece. So did just about everybody else. That big piece could be a major catalyst for Hypha Labs (OTCQB: FUNI) which makes the first at-home and commercial patent-pending mushroom ingredient maker of its kind. The elevator pitch is that Hypha Labs is to mushrooms as the clever Keurig was, is, to coffee. Massive potential disruptor in a massive market. Hypha's story is already a game changer as it is going to allow the soccer mom at home to make her preferred mushroom ingredient in a simple eight-day cycle. Pop in a cartridge, scan the bar code, wait eight days and enjoy the magic of the mushroom. Total privacy, no more growing 'shrooms in animal feces. But the mushroom industry is a decade or more behind the Emancipation of Cannabis. That cannabis revolution has almost completely come already with weed available most everywhere and a reasonable expectation that the government will change the arcane way it is classified/scheduled at the federal level. The cannabis movement started simply enough; some vocal folk argued the medicinal benefits AND the economic benefits to states that would listen and states started to go green. Once a few states implemented pro-Cannabis legislation they provided good working test market examples for other states to see that there wasn't a new filming of Reefer Madness on the streets and there were indeed many a cannabis driven dollar going into the state coffers that could be used for things like better schools and roads. I've buried the lead here but then again, it's been buried for a long, long time. Don't kill the messenger. Here's the buried bombshell: The Drug Enforcement Agency (DEA) appears to have taken a firm position that mycelium is ok to ship across state lines, although there are three states which currently don't allow mycelium to be shipped across state lines. Mycelium is the inactive root-like structure which later becomes a mushroom when it begins to fruit, which is what happens when it is fed nutrients. That's pretty good news if you're a company like Hypha Labs that will ship mycelium across eligible state lines once the retail roll-out of the Micropearls machine goes live. As described, Hypha sends you mycelium and based on your desires and a little A.I. you set your eight day harvest to whatever mushroom crop you're feelin'. Here are two sources for the D.E.A.'s position, which of course, come from cannabis sources who know what this means for the mushroom. One has an actual letter from the D.E.A. to the inquiring attorney way down at the bottom of the page. Read that. Click on either headline to read the coverage: DEA CONFIRMS PSYCHEDELIC MUSHROOM SPORES ARE LEGAL DEA Confirms That Psychedelic Mushroom Spores Are Federally Legal Prior To Germination (DEA letter at the bottom.) What is absolutely bizarre is we can find ZERO national news coverage other than these industry blogs. And we are good at Googling. This means you are among the very few who knows about the milestone moment for mycelium and mushrooms and what an absolute gamechanger it is for Hypha Labs and their magical Micropearls. Editor's Note:As this article was being prepared for release, breaking news from New Mexico warrants mention. The state's governor has signed a bill allowing for psilocybin use in the state. As indicatedin this release from Hypha, this is a massive step forward to acceptance and a rapidly expanding market for Hypha Lab's revolutionary Micro Pearls device. More on Hypha here. We intend to cover Hypha Labs for the next couple months at minimum and to closely track their development and execution of their business model. If you see what we see, we suggest you add the ticker 'FUNI' to your watchlist and take a moment to review the Company's Investor Presentation at the following link: About The Emerging Markets Report: The Emerging Markets Report is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing years of experience. Our network consists of stockbrokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets. For more informative reports such as this, please sign up at Must Read OTC Markets/SEC policy on stock promotion and investor protection Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below. We may purchase Securities of the Profiled Company prior to their securities becoming publicly traded, which we may later sell publicly before, during or after our dissemination of the Information, and make profits therefrom. EMC does not verify or endorse any medical claims for any of its client companies. The Company's external Investor Relations firm, Integrity Media Inc, has contributed significantly to this report and holds or is owed six-million shares through a current or previous service agreement. EMC has been paid $50,000 by Hypha Labs on its own behalf for various marketing services including this report. EMC does not independently verify any of the content linked to this editorial. Please see our full disclaimer. For media inquiries, please contact Maggie Caraway at [email protected]
Yahoo
12-02-2025
- Business
- Yahoo
Emerging Markets Report: Breakthroughs & Bureaucracy
Potential Regulatory Changes and an Epic Breakthrough in the Lab Bode Well for Hypha Labs and the Magic of the Mushroom An Emerging Markets Sponsored Commentary ORLANDO, Fla., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Not sure Hypha Labs (OTCQB: FUNI) could have had a better week than it did last week. Imagine if Tesla got news that more states were going to look to mandate electric cars, greatly widening the EV company's market opportunity. Now, imagine if Tesla's engineers said they had a breakthrough in the laboratory and now their electric batteries can go five times as far on one charge. That hypothetical aside, this is the kind of week Hypha Labs just had. First, Hypha isn't exactly the kind of Company that pushes news out every week, feeding the market faint reminders that they exist. Two releases in a week are unusual for the Company that is going to market with the first in-home and commercial device of its kind to produce the finest functional mushroom ingredients in eight days or so using a compact device that easily sits on a residential countertop. You read that right. Hypha Labs enables a person in their home to make a wide array of mushroom ingredients and is producing a commercial unit to grow the good stuff at scale for Big Pharma, restaurateurs, food makers… anyone who wants to harness the magic of the mushroom. Intrigued? A full investor deck is available here once you're done reading this editorial. Earlier in the week, Hypha dropped news acknowledging a significant movement to change laws and regulations around mushroom use. And while there is already a massive functional mushroom market (over $31 billion in 2024), regulatory changes could greatly widen the types of mushrooms that can be consumed which would A) add that mushroom revenue to the overall legal mushroom industry and B) highlight the overall mushroom benefits of mushroom consumption. Read this article when you get a second and ask yourself if this sure doesn't sound a lot like the early cannabis political changes that led to the massive legal cannabis industry we see today. Even still, growing cannabis at home was easily achievable for many people. It's not the most difficult crop. There's a reason they call it 'weed.' Growing quality functional mushroom ingredients is much more challenging and current processes like growing mushrooms in animal excrement don't seem so well-suited for the kitchen counter. Hypha will not likely see the type of competition to grow mushroom products that cannabis devices did and do. For some time we've hammered home the fact that we think that Hypha Lab's elegant device is a game-changer, a revolutionary model in an industry that we see is rapidly growing and ascendant. So when we see news that the R&D team at Hypha Labs had a breakthrough in the lab and now the yields for a home user in the brief eight-day grow cycle are up 500% it more than turns our heads. We're sorting through decades of being in American markets and searching for a time when a Company posted FIVE-HUNDRED-PERCENT gains in production. An example does not readily come to mind. It's a remarkable achievement and for us, it means that a device that is first of its kind in so many ways just got exponentially more appealing and productive, more compelling to purchase in the first place, and more likely to churn future product purchases vis-à-vis Hypha's evergreen customer relationship with their razor/razor blade model wherein the customer must re-purchase the proprietary grow solutions from Hypha for each yield. It was indeed a week of breakthroughs for the Las Vegas-based mushroom innovator, and perhaps, the beginning of the end of massive bureaucracy for the amazing mushroom. More on Hypha We intend to cover Hypha Labs for the next couple of months at minimum and to closely track the development and execution of their business you see what we see, we suggest you add the ticker 'FUNI' to your watchlist and take a moment to review the Company's Investor Presentation at the following link: About The Emerging Markets Report:The Emerging Markets Report is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing years of experience. Our network consists of stockbrokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets. For more informative reports such as this, please sign up at Must Read OTC Markets/SEC policy on stock promotion and investor protection Section 17(b) of the Securities Act of 1933 requires that any person who uses the mail to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive certain compensation in the future, as described below. We may purchase Securities of the Profiled Company prior to their securities becoming publicly traded, which we may later sell publicly before, during, or after our dissemination of the Information, and make profits therefrom. EMC does not verify or endorse any medical claims for any of its client companies. EMC has been paid $50,000 CUMULATIVE by Hypha Labs on its own behalf for various marketing services including this report. EMC does not independently verify any of the content linked to this editorial. Please see our full disclaimer. For media inquiries, please contact Maggie Caraway at maggie@
